These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
494 related items for PubMed ID: 19142131
41. [Changes of retinal ganglion cells and expression of Bad after optic nerve crush in rats]. Wu HS, Ke J, Chen XR. Fa Yi Xue Za Zhi; 2006 Aug 15; 22(4):258-60. PubMed ID: 17080661 [Abstract] [Full Text] [Related]
42. Topical nipradilol: effects on optic nerve head circulation in humans and periocular distribution in monkeys. Mizuno K, Koide T, Saito N, Fujii M, Nagahara M, Tomidokoro A, Tamaki Y, Araie M. Invest Ophthalmol Vis Sci; 2002 Oct 15; 43(10):3243-50. PubMed ID: 12356831 [Abstract] [Full Text] [Related]
43. Changes of retinal glutamate transporter GLT-1 mRNA levels following optic nerve damage. Mawrin C, Pap T, Pallas M, Dietzmann K, Behrens-Baumann W, Vorwerk CK. Mol Vis; 2003 Jan 13; 9():10-3. PubMed ID: 12533722 [Abstract] [Full Text] [Related]
44. Neuroprotective effect of 4-(Phenylsulfanyl)butan-2-one on optic nerve crush model in rats. Chien JY, Sheu JH, Wen ZH, Tsai RK, Huang SP. Exp Eye Res; 2016 Feb 13; 143():148-57. PubMed ID: 26472213 [Abstract] [Full Text] [Related]
45. Resistance of retinal ganglion cells to an increase in intraocular pressure is immune-dependent. Bakalash S, Kipnis J, Yoles E, Schwartz M. Invest Ophthalmol Vis Sci; 2002 Aug 13; 43(8):2648-53. PubMed ID: 12147598 [Abstract] [Full Text] [Related]
46. Retinal ganglion cell and nonneuronal cell responses to a microcrush lesion of adult rat optic nerve. Sellés-Navarro I, Ellezam B, Fajardo R, Latour M, McKerracher L. Exp Neurol; 2001 Feb 13; 167(2):282-9. PubMed ID: 11161616 [Abstract] [Full Text] [Related]
47. A novel neuroprotective role of a small peptide from flesh fly, 5-S-GAD in the rat retina in vivo. Koriyama Y, Tanii H, Ohno M, Kimura T, Kato S. Brain Res; 2008 Nov 13; 1240():196-203. PubMed ID: 18823958 [Abstract] [Full Text] [Related]
48. Changes in gene expression in experimental glaucoma and optic nerve transection: the equilibrium between protective and detrimental mechanisms. Yang Z, Quigley HA, Pease ME, Yang Y, Qian J, Valenta D, Zack DJ. Invest Ophthalmol Vis Sci; 2007 Dec 13; 48(12):5539-48. PubMed ID: 18055803 [Abstract] [Full Text] [Related]
49. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Bosco A, Inman DM, Steele MR, Wu G, Soto I, Marsh-Armstrong N, Hubbard WC, Calkins DJ, Horner PJ, Vetter ML. Invest Ophthalmol Vis Sci; 2008 Apr 13; 49(4):1437-46. PubMed ID: 18385061 [Abstract] [Full Text] [Related]
50. α-Crystallin protects RGC survival and inhibits microglial activation after optic nerve crush. Wu N, Yu J, Chen S, Xu J, Ying X, Ye M, Li Y, Wang Y. Life Sci; 2014 Jan 14; 94(1):17-23. PubMed ID: 24220677 [Abstract] [Full Text] [Related]
51. Dosage dependence of the effect of Ginkgo biloba on the rat retinal ganglion cell survival after optic nerve crush. Ma K, Xu L, Zhan H, Zhang S, Pu M, Jonas JB. Eye (Lond); 2009 Jul 14; 23(7):1598-604. PubMed ID: 18820658 [Abstract] [Full Text] [Related]
52. Critical role of calpain in axonal damage-induced retinal ganglion cell death. Ryu M, Yasuda M, Shi D, Shanab AY, Watanabe R, Himori N, Omodaka K, Yokoyama Y, Takano J, Saido T, Nakazawa T. J Neurosci Res; 2012 Apr 14; 90(4):802-15. PubMed ID: 22065590 [Abstract] [Full Text] [Related]
53. Neuroprotective effect on retinal ganglion cells by transpupillary laser irradiation of the optic nerve head. Ma J, Jiang L, Zhong Y, Li Z, Xie J, Zhao C, Dong F. Neurosci Lett; 2010 May 26; 476(1):3-8. PubMed ID: 20060436 [Abstract] [Full Text] [Related]
54. Quantitative iTRAQ analysis of retinal ganglion cell degeneration after optic nerve crush. Magharious M, D'Onofrio PM, Hollander A, Zhu P, Chen J, Koeberle PD. J Proteome Res; 2011 Aug 05; 10(8):3344-62. PubMed ID: 21627321 [Abstract] [Full Text] [Related]
55. Effects of topical nipradilol, a beta-blocking agent with alpha-blocking and nitroglycerin-like activities, on aqueous humor dynamics and fundus circulation. Kanno M, Araie M, Tomita K, Sawanobori K. Invest Ophthalmol Vis Sci; 1998 Apr 05; 39(5):736-43. PubMed ID: 9538880 [Abstract] [Full Text] [Related]
56. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Zhong L, Bradley J, Schubert W, Ahmed E, Adamis AP, Shima DT, Robinson GS, Ng YS. Invest Ophthalmol Vis Sci; 2007 Mar 05; 48(3):1212-8. PubMed ID: 17325165 [Abstract] [Full Text] [Related]
57. A new experimental model of glaucoma in rats through intracameral injections of hyaluronic acid. Moreno MC, Marcos HJ, Oscar Croxatto J, Sande PH, Campanelli J, Jaliffa CO, Benozzi J, Rosenstein RE. Exp Eye Res; 2005 Jul 05; 81(1):71-80. PubMed ID: 15978257 [Abstract] [Full Text] [Related]
58. Quantitative retinal protein analysis after optic nerve transection reveals a neuroprotective role for hepatoma-derived growth factor on injured retinal ganglion cells. Hollander A, D'Onofrio PM, Magharious MM, Lysko MD, Koeberle PD. Invest Ophthalmol Vis Sci; 2012 Jun 26; 53(7):3973-89. PubMed ID: 22531700 [Abstract] [Full Text] [Related]
59. Blocking LINGO-1 function promotes retinal ganglion cell survival following ocular hypertension and optic nerve transection. Fu QL, Hu B, Wu W, Pepinsky RB, Mi S, So KF. Invest Ophthalmol Vis Sci; 2008 Mar 26; 49(3):975-85. PubMed ID: 18326721 [Abstract] [Full Text] [Related]
60. In vivo imaging and counting of rat retinal ganglion cells using a scanning laser ophthalmoscope. Higashide T, Kawaguchi I, Ohkubo S, Takeda H, Sugiyama K. Invest Ophthalmol Vis Sci; 2006 Jul 26; 47(7):2943-50. PubMed ID: 16799037 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]